Zai Lab Limited operates as a biopharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Next Day Disclosure Return

Announcements and Notices - [Share Scheme]

Grant Of Restricted Share Units

Announcements and Notices - [Placing / Issue of Shares under a General Mandate]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zai Lab (9688 HK)

Next Day Disclosure Return

Grant Of Restricted Share Units

Voluntary Announcement - Closing Of The Offering Of American Depositary Shares And Full Exercise Of The Option

Next Day Disclosure Return

Grant Of Restricted Share Units

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)